MedPath

Verticalization Robotic Exoskeleton DoC

Not Applicable
Conditions
Brain Injuries
Disorder of Consciousness
Interventions
Other: Robotic Mobility Device (REX)
Other: Tilt Table
Registration Number
NCT04833543
Lead Sponsor
Memorial Hermann Health System
Brief Summary

Mobilization, specifically verticalization, has been shown to play a role in enhancing consciousness. Vestibular stimulation has the potential to influence the neural substrate of consciousness, but this modality has not been thoroughly explored. The primary aim of this study is to compare the influence of verticalization with and without vestibular input on level of consciousness in patients experiencing disorders of consciousness (DoC).

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
10
Inclusion Criteria
  1. unresponsive wakefulness syndrome/vegetative state (UWS/VS) or minimally conscious state (MCS) following traumatic brain injury (TBI), intracerebral bleeding, ischemic infarction, or hypoxic brain injury
  2. Medical clearance by a physician
  3. 18-75 years old
  4. Mobilization into standing for at least 10 minutes without signs of orthostasis
Exclusion Criteria
  1. Time since injury less than 4 weeks or more than 6 months

  2. Mobilization into standing lasts more than 30 minutes

  3. Severe osteoporosis

  4. Muscle tone that prevents joint motion (Modified Ashworth Scale (MAS) 4)

  5. Unstable fractures

  6. Decubiti on areas contacted by robotic mobility device (i.e. heels, tibia, greater trochanter, ischial tuberosity, sacrum)

  7. Inability to fit device requirements*

    • Height 4'8"-6'4", Weight 88-222 lbs., Hip Flexion 0-90˚, Knee Flexion 0-90˚, Plantigrade

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Robotic Mobility Device (REX)Robotic Mobility Device (REX)-
Tilt TableTilt Table-
Primary Outcome Measures
NameTimeMethod
Coma Recovery Scale-Revised (CRS-R)through study completion; an average of 8 weeks

scores range from 0-23; higher scores mean a better outcome

Secondary Outcome Measures
NameTimeMethod
Modified Ashworth Scale (MAS)through study completion; an average of 8 weeks

scores range from 0-4; lower scores mean a better outcome

Trial Locations

Locations (1)

TIRR Memorial Hermann

🇺🇸

Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath